×
About 15,057 results

ALLMedicine™ Hypertrophic Cardiomyopathy Center

Research & Reviews  7,297 results

Unmet needs in the treatment of hypertrophic cardiomyopathy.
https://doi.org/10.2217/fca-2020-0242
Future Cardiology; Hutt E, Nissen SE et. al.

May 7th, 2021 - Hypertrophic cardiomyopathy (HCM) is a complex heterogeneous cardiovascular disorder characterized by hypertrophied and disorganized myocytes with varying degrees of interstitial fibrosis. The current management strategies include genetic and fami...

Hypertrophic Cardiomyopathy: A Species-Spanning Pathology.
https://doi.org/10.1053/j.jvca.2021.03.040
Journal of Cardiothoracic and Vascular Anesthesia; Horowitz BN

May 3rd, 2021 - Hypertrophic Cardiomyopathy: A Species-Spanning Pathology.|2021|Horowitz BN,|

LV apical aneurysm in HCM: Implant ICD and anticoagulate?: Editorial comment on: "Progn...
https://doi.org/10.1016/j.ijcard.2021.04.044
International Journal of Cardiology; Kampaktsis PN, Tzoumas A

May 1st, 2021 - LV apical aneurysm in HCM: Implant ICD and anticoagulate?: Editorial comment on: "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis."|2021|Kampaktsis PN,Tzoumas A,|

Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy.
https://doi.org/10.1016/j.jacc.2021.03.008
Journal of the American College of Cardiology; Cui H, Schaff HV et. al.

Apr 30th, 2021 - Hypertrophic cardiomyopathy (HCM) is characterized by multiple pathological features including myocyte hypertrophy, myocyte disarray, and interstitial fibrosis. This study sought to correlate myocardial histopathology with clinical characteristics...

Evaluating Histopathology to Improve Our Understanding of Hypertrophic Cardiomyopathy.
https://doi.org/10.1016/j.jacc.2021.03.292
Journal of the American College of Cardiology; Rowin EJ, Fifer MA

Apr 30th, 2021 - Evaluating Histopathology to Improve Our Understanding of Hypertrophic Cardiomyopathy.|2021|Rowin EJ,Fifer MA,|

see more →

Guidelines  23 results

2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic ca...
https://doi.org/10.1016/j.jtcvs.2021.04.001
The Journal of Thoracic and Cardiovascular Surgery; , Ommen SR et. al.

Apr 30th, 2021 - 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2021| ,Ommen SR,Mital S...

ACR Appropriateness Criteria® Nonischemic Myocardial Disease with Clinical Manifestatio...
https://doi.org/10.1016/j.jacr.2021.01.019
Journal of the American College of Radiology : JACR; , Rajiah P et. al.

Mar 2nd, 2021 - Nonischemic cardiomyopathies encompass a broad spectrum of myocardial disorders with mechanical or electrical dysfunction without evidence of ischemia. There are five broad variants of nonischemic cardiomyopathies; hypertrophic cardiomyopathy (Var...

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Ca...
https://doi.org/10.1016/j.jacc.2020.08.045
Journal of the American College of Cardiology; Ommen SR, Mital S et. al.

Nov 24th, 2020 - 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2020|Ommen SR,Mital S,B...

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Ca...
https://doi.org/10.1016/j.jacc.2020.08.044
Journal of the American College of Cardiology; Ommen SR, Mital S et. al.

Nov 24th, 2020 - This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting d...

Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy
https://jamanetwork.com/journals/jamacardiology/fullarticle/2733139

May 21st, 2019 - Question Is it possible to identify most patients with hypertrophic cardiomyopathy (HCM) at risk of arrhythmic sudden cardiac death (SCD) and to prevent such events with prophylactic implantable cardioverter/defibrillators (ICDs)? Findings In t...

see more →

Clinicaltrials.gov  7,493 results

Unmet needs in the treatment of hypertrophic cardiomyopathy.
https://doi.org/10.2217/fca-2020-0242
Future Cardiology; Hutt E, Nissen SE et. al.

May 7th, 2021 - Hypertrophic cardiomyopathy (HCM) is a complex heterogeneous cardiovascular disorder characterized by hypertrophied and disorganized myocytes with varying degrees of interstitial fibrosis. The current management strategies include genetic and fami...

Hypertrophic Cardiomyopathy: A Species-Spanning Pathology.
https://doi.org/10.1053/j.jvca.2021.03.040
Journal of Cardiothoracic and Vascular Anesthesia; Horowitz BN

May 3rd, 2021 - Hypertrophic Cardiomyopathy: A Species-Spanning Pathology.|2021|Horowitz BN,|

LV apical aneurysm in HCM: Implant ICD and anticoagulate?: Editorial comment on: "Progn...
https://doi.org/10.1016/j.ijcard.2021.04.044
International Journal of Cardiology; Kampaktsis PN, Tzoumas A

May 1st, 2021 - LV apical aneurysm in HCM: Implant ICD and anticoagulate?: Editorial comment on: "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis."|2021|Kampaktsis PN,Tzoumas A,|

Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy.
https://doi.org/10.1016/j.jacc.2021.03.008
Journal of the American College of Cardiology; Cui H, Schaff HV et. al.

Apr 30th, 2021 - Hypertrophic cardiomyopathy (HCM) is characterized by multiple pathological features including myocyte hypertrophy, myocyte disarray, and interstitial fibrosis. This study sought to correlate myocardial histopathology with clinical characteristics...

Evaluating Histopathology to Improve Our Understanding of Hypertrophic Cardiomyopathy.
https://doi.org/10.1016/j.jacc.2021.03.292
Journal of the American College of Cardiology; Rowin EJ, Fifer MA

Apr 30th, 2021 - Evaluating Histopathology to Improve Our Understanding of Hypertrophic Cardiomyopathy.|2021|Rowin EJ,Fifer MA,|

see more →

News  205 results

New HCM Guidelines Make Shared Decision-making Top Priority
https://www.medscape.com/viewarticle/941365

Nov 19th, 2020 - Greater involvement of the patient and family in decision-making, clarity on the role of genetic testing and parameters for team-oriented care, and use of high-volume specialty centers are cornerstones of the first update in almost a decade of the...

Surgery Still Best Option in Obstructive HCM Despite EXPLORER-HCM Results
https://www.staging.medscape.com/viewarticle/939029

Oct 14th, 2020 - Among the landmark presentations at the recent European Society of Cardiology virtual congress was the presentation on the EXPLORER-HCM randomized controlled trial. In this study, simultaneously published in The Lancet, the investigational drug ma...

Surgery Still Best Option in Obstructive HCM Despite EXPLORER-HCM Results
https://www.medscape.com/viewarticle/939029

Oct 14th, 2020 - Among the landmark presentations at the recent European Society of Cardiology virtual congress was the presentation on the EXPLORER-HCM randomized controlled trial. In this study, simultaneously published in The Lancet, the investigational drug ma...

EXPLORER Trial Hints at Potential New Drug Option in Obstructive Hypertrophic Cardiomyopathy
https://www.staging.medscape.com/viewarticle/936542

Aug 28th, 2020 - An investigational drug that targets part of the molecular machinery underlying obstructive hypertrophic cardiomyopathy (HCM) can improve both symptoms and functional status in patients with the genetic disorder, suggests a placebo-controlled phas...

EXPLORER Trial Hints at Potential New Drug Option in Obstructive Hypertrophic Cardiomyopathy
https://www.medscape.com/viewarticle/936542

Aug 28th, 2020 - An investigational drug that targets part of the molecular machinery underlying obstructive hypertrophic cardiomyopathy (HCM) can improve both symptoms and functional status in patients with the genetic disorder, suggests a placebo-controlled phas...

see more →

Patient Education  39 results see all →